Search Results 671-680 of 26099 for jhajjarcancer
Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can block ...
Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether temozolomide is more ...
Hello, my name is Joe Murray. I'm a gastroenterologist in the Celiac Disease Program at Mayo Clinic. One of the challenges of following our patients with ...
About this study. Determine an underlying etiology behind unexpectedly severe reactions to radiation by blood draw. Participation eligibility.
Aim 2 (Biomarkers). To identify and characterize clinical, histological, molecular, and genetic biomarkers that are linked to glomerular disease, disease ...
This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics. Participation eligibility. Participant ...
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder.
Mayo Clinic researcher Naveen L. Pereira, M.D., performs resequencing studies to describe genetic variations using molecular techniques in population-based ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The aim of the clinical trial is evaluate the EndoRotor®'s ability to completely remove areas of Barrett's metaplasia considered ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.